While globalisation and the rapid development of innovative new drugs are contributing to improved human health, it is also introducing additional challenges for sponsors to overcome and comparator sourcing is no exception.

A shortfall in comparator drug availability can have a domino effect on the entire clinical supply chain; jeopardising vital study timelines and negatively impacting both patients and commercial performance. With one in three trial operators experiencing out-of-stock problems when attempting to source comparator products, this is fast becoming an industry-wide problem, with wider implications that simply cannot be ignored.

In this case study, we look at how Almac’s swift actions enabled a sponsor to uphold patient experience and enjoy operational continuity, free from disruption or delay, throughout the duration of its study.

Download to find out more